Application no. and date | 01939923.7 (espacenet) (Federated) (European Patent Register), 20010606 | Patent/reg. no. and date | DK/EP 1292315, 20080924 | Publication date | 20030319 | Priority no. and date | US 209907 P, 20000607 | EP pub. no. and date |
EP 1292315 20030319 | Effective date | | Applicant/owner | Alfa Wassermann, Inc., 4 Henderson Drive
West Caldwell, NJ 07006, US | Applicant ref. no. | P44213DK01 | Inventor | PALAZZINI, Ernesto, Via Broccaindosso, 23
I-40125 Bologna, IT, GAMBARO, Giovanni, Via S. Abrogioa, 2
I-30037 Scorze, IT | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/737 (2006.01) , A61P 13/12 (2006.01) | Title | Anvendelse af sulodexid til behandling af diabetisk nefropati | Int. application no. | US2001018411 | Int. publication no. | WO2001093850 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|